Starting Insulin Therapy in Type 2 Diabetes: Twice-Daily Biphasic Insulin Aspart 30 Plus Metformin versus Once-Daily Insulin Glargine Plus Glimepiride

PH Kann, Thomas C. Wascher, Viera Žáčková, Johannes Moeller, J Medding, Albert Szöcs, Marián Mokáň, Franc Mrevlje, M Regulski

Experimental and Clinical Endocrinology & Diabetes · 2006 · 112 citations · 0 references

DOI

Abstract

Starting insulin in Type 2 diabetes patients with twice-daily BIAsp 30 plus met can reduce HbA (1c) and mean prandial plasma glucose increment to a greater extent than once-daily glarg plus glim.